Viewpoint is a radiopharmaceutical company developing precision α-particle oncology therapeutics and complementary diagnostic imaging agents.
Joined August 2016
- Tweets 172
- Following 63
- Followers 1,688
- Likes 24
95 Photos and videos
6 Jan 2023
Viewpoint Molecular Targeting is presenting at #BiotechShowcase! Join us in San Francisco this January 9th at 10:00 am PST to attend our presentation about our pipeline featuring our leading lead-212-based alpha-particle radiotherapies. Register: lnkd.in/gJD8Vydc
187
28 Feb 2022
Have you seen our new MOA video? If not, be sure to check it out here: vimeo.com/654514833/fa84fc5e…
#Theranostics #Radiopharmaceuticals #MetastaticMelanoma #NeuroendocrineTumors
1
ViewpointMT retweeted
13 Jan 2022
Have you seen our new MOA video? If not, be sure to check it out here: vimeo.com/654514833/fa84fc5e…
#Theranostics #Radiopharmaceuticals #MetastaticMelanoma #NeuroendocrineTumors
3
1
4
22 Feb 2022
Viewpoint Molecular Targeting® to Present at the B. Riley Radiation Oncology Investor Day.
bit.ly/3sbDYik
@BRileyFinancial #Theragnostics #Radiopharmaceuticals #Radiotherapy
1
1
22 Feb 2022
Viewpoint Molecular Targeting® Appoints Thijs Spoor as Chief Executive Officer.
bit.ly/33F25fB
#Theragnostics #Radiopharmaceuticals #Radiotherapy
2
1
15 Feb 2022
Sign up for email alerts to stay up to date with our latest communications and happenings! bit.ly/3hTazEo
#Radiopharmaceuticals #Theranostics
1
1
9 Feb 2022
4 in 10 #cancer diagnoses in the U.S. are associated with preventable risk factors. In recognition of #NationalCancerPreventionMonth, we encourage you to learn more at bit.ly/3r3yvcI.
@AACRFoundation
1
4 Feb 2022
Today is #WorldCancerDay. This year’s focus is on understanding and recognizing the inequities in cancer care around the globe. Learn more and how you can help to #CloseTheCareGap here: bit.ly/2E0iGLK
#Radiopharmaceuticals #Theranostics
1
1
31 Jan 2022
Dr. Michael K. Schultz, Co-Founder and Chief Science Officer of Viewpoint, provides insight behind the power of theranostics to cancer therapy.
@InvestorVirtual #VirtualInvestor #Theranostics #Radiopharmaceuticals #MetastaticMelanoma #NeuroendocrineTumors
2
2
25 Jan 2022
We are presenting today at 11:00 AM ET at the JTC #VirtualInvestor 2022 Top Picks Conference. Access our webcast at bit.ly/3F6gNJf
@InvestorVirtual
1
1
21 Jan 2022
#DontMissIt! We are presenting at the upcoming JTC #VirtualInvestor 2022 Top Picks Conference on Tuesday, January 25th at 11:00 AM ET. Pre-submit your questions here: bit.ly/3pTkXjP
@InvestorVirtual
1
1
20 Jan 2022
Viewpoint Molecular Targeting® to Present at the Virtual Investor 2022 Top Picks Conference.
bit.ly/3rEpq9r
@InvestorVirtual #VirtualInvestor
2
19 Jan 2022
Our Co-Founder and CSO, Dr. Michael K. Schultz, has confidence in the Company’s approach to developing alpha-particle #radiopharmaceuticals.
#Theranostics #MetastaticMelanoma #NeuroendocrineTumors @InvestorVirtual #VirtualInvestor
1
ViewpointMT retweeted
12 Jan 2022
We are hosting the 2022 Top Picks Conference January 25-27, 2022. Access the event, its schedule and pre-submit questions at: bit.ly/3pTkXjP
$AEZS $AREC $AIM $CZO $CRBP $CNSP $CYTH $NVNO @iTolerance_inc @Melzi_Surgical $MBRX $OTLK $SING $VLON @Viewpoint_MT $XBIO
15
23
57
12 Jan 2022
Our Co-Founder and CEO, Dr. Frances L. Johnson, highlights our unique approach to developing #radiopharmaceuticals.
#Theranostics #MetastaticMelanoma #NeuroendocrineTumors @InvestorVirtual #VirtualInvestor
10 Jan 2022
#DontMissIt: Our presentation at the H.C. Wainwright BioConnect Conference is now available! Access the webcast here: bit.ly/3JGjNzq
@HCWCO #HCWCO
1
7 Jan 2022
#MarkYourCalendars: We are participating in the upcoming H.C. Wainwright BioConnect Conference. Access the event here: bit.ly/3JGjNzq
@HCWCO #HCWCO
2
5 Jan 2022
Viewpoint Molecular Targeting® to Present at the H.C. Wainwright BioConnect Conference.
bit.ly/3G35XVJ
@HCWCO #HCWCO #Radiopharmaceuticals #Theranostics #MetastaticMelanoma #NeuroendocrineTumors
1
3